Dopamine D1/5 and D2/3 agonists differentially attenuate somatic signs of nicotine withdrawal in rats

Pharmacology Biochemistry and Behavior

Volumn 99, Issue 4, 2011, Pages 552-556

  Ohmura, Yu ^a,b   Jutkiewicz, Emily M ^a   Zhang, Andrew ^a   Domino, Edward F ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Addiction; Smoking; Tobacco; Withdrawal syndrome

Indexed keywords

6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; NICOTINE TARTRATE; PRAMIPEXOLE; BENZAZEPINE DERIVATIVE; BENZOTHIAZOLE DERIVATIVE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 5 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; NICOTINE; NICOTINIC AGENT; PRAMIPEXOL; SK&F 81297;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENUATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; LOW DRUG DOSE; MALE; MASTICATION; NICOTINE WITHDRAWAL; NONHUMAN; OSMOTIC PUMP; PRIORITY JOURNAL; PTOSIS; RAT; SMOKING CESSATION; WITHDRAWAL SYNDROME; YAWNING; ANALYSIS OF VARIANCE; ANIMAL; ANIMAL BEHAVIOR; DRUG IMPLANT; DRUG POTENTIATION; METABOLISM; PSYCHOLOGICAL ASPECT; SPRAGUE DAWLEY RAT; SUBCUTANEOUS DRUG ADMINISTRATION; TOBACCO DEPENDENCE;

NICOTIANA TABACUM; RATTUS;

ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; BENZAZEPINES; BENZOTHIAZOLES; DOPAMINE; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG IMPLANTS; INJECTIONS, SUBCUTANEOUS; MALE; NICOTINE; NICOTINIC AGONISTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; RECEPTORS, DOPAMINE D5; SUBSTANCE WITHDRAWAL SYNDROME; TOBACCO USE DISORDER;

EID: 79959337264     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2011.05.010     Document Type: Article

References (33)

1. 1 dopamine receptors attenuates cue reinstatement of extinguished cocaine-seeking behavior in rats Psychopharmacol 159 2002 284 293 (Pubitemid 34143377)
2. K.E. Asin, L. Bednarz, A. Nikkei, and R. Perner Rotation and striatal c-fos expression after repeated daily treatment with selective dopamine receptor agonists and levodopa J Pharmacol Exper Ther 273 1995 1483 1490
3. 1 receptor stimulation on rotation and c-fos expression Eur J Pharmacol 235 1992 167 168
4. N.L. Benowitz, F. Kuyt, and P. Jacob III Circadian blood nicotine concentrations during cigarette smoking Clin Pharmacol Ther 32 1982 758 764 (Pubitemid 13093847)
5. 3 receptor-mediated behavior J Pharmacol Exp Ther 314 2005 310 319 (Pubitemid 41058268)
6. 2 agonists and antagonists Psychopharmacol 193 2007 159 170 (Pubitemid 47025018)
7. G.T. Collins, D.M. Calinski, A.H. Newman, P. Grundt, and J.H. Woods Food restriction alters N′-propyl-4,5,6,7-tetrahydrobenzothiazole-2,6-diamine dihydrochloride (pramipexole)-induced yawning, hypothermia, and locomotor activity in rats: evidence for sensitization of dopamine D2 receptor-mediated effects J Pharmacol Exp Ther 325 2008 691 697 (Pubitemid 351574782)
8. 3 receptor in rats and mice J Pharmacol Exp Ther 329 2009 210 217
9. 1 receptor binding in the ventral striatum of cigarette smokers Synapse 42 2001 48 53 (Pubitemid 32786423)
10. E.F. Domino, and H. Tsukada Nicotine sensitization of monkey striatal dopamine release Eur J Pharmacol 607 2009 91 95
11. A.M. Duchemin, H. Zhang, N.H. Neff, and M. Hadjiconstantinou Increased expression of VMAT2 in dopaminergic neurons during nicotine withdrawal Neurosci Lett 467 2009 182 186
12. Y.K. Fung, M.J. Schmid, T.M. Anderson, and Y.S. Lau Effects of nicotine withdrawal on central dopaminergic systems Pharmacol Biochem Behav 53 1996 635 640 (Pubitemid 26086452)
13. T.D. Geracioti, A.S. West, D.G. Baker, K.K. Hill, N.N. Ekhator, M.D. Wortman, P.E. Keck, and A.B. Norman Low CSF concentration of dopamine metabolite in tobacco smokers Am J Psychiat 156 1999 130 132 (Pubitemid 29034891)
14. K.R. Hamilton, S.S. Berger, M.E. Perry, and N.E. Grunberg Behavioral effects of nicotine withdrawal in adult male and female rats Pharmacol Biochem Behav 92 2009 51 59
15. B.E. Hildebrand, G.G. Nomikos, P. Hertel, B. Schilström, and T.H. Svensson Reduced dopamine output in the nucleus accumbens but not in the medial prefrontal cortex in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome Brain Res 779 1998 214 225 (Pubitemid 28039954)
16. J.R. Hughes Effects of abstinence from tobacco: etiology, animal models, epidemiology, and significance: a subjective review Nicotine Tob Res 9 2007 329 339 (Pubitemid 46404265)
17. J.R. Hughes Smoking and suicide: a brief overview Drug Alcohol Depend 98 2008 169 178
18. 3-preferring agonists in rats Psychopharmacol 203 2009 317 327
19. M.G. LeSage, D.E. Keyler, D. Shoeman, D. Raphael, G. Collins, and P.R. Pentel Continuous nicotine infusion reduces nicotine self-administration in rats with 23-h/day access to nicotine Pharmacol Biochem Behav 72 2002 279 289 (Pubitemid 34251337)
20. J. Maj, Z. Rogóz, G. Skuza, and K. Kołodziejczyk Antidepressant effects of pramipexole, a novel dopamine receptor agonist J Neural Transm 104 1997 525 533 (Pubitemid 27379907)
21. D.H. Malin, and P. Goyarzu Rodent models of nicotine withdrawal syndrome Handb Exp Pharmacol 192 2009 401 434
22. D.H. Malin, J.R. Lake, P. Newlin-Maultsby, L.K. Roberts, J.G. Lanier, V.A. Carter, J.S. Cunningham, and O.B. Wilson Rodent model of nicotine abstinence syndrome Pharmacol Biochem Behav 43 1992 779 784
23. D.H. Malin, J.R. Lake, T.D. Smith, H.N. Khambati, R.L. Meyers-Paal, A.L. Montellano, R.E. Jennings, D.S. Erwin, S.E. Presley, and B.A. Perales Bupropion attenuates nicotine abstinence syndrome in the rat Psychopharmacol 184 2006 494 503 (Pubitemid 43255866)
24. Ohmura Y, Jutkiewicz E Domino EF: L-DOPA attenuates rat nicotine withdrawal-induced behaviors. Pharmacol. Biochem. Behav. In press, 2011.
25. K.N. Paperwalla, T.T. Levin, J. Weiner, and S.M. Saravay Smoking and depression Med Clin North Am 88 2004 1483 1494 (Pubitemid 39298740)
26. N.E. Paterson, S. Semenova, and A. Markou The effects of chronic versus acute desipramine on nicotine withdrawal and nicotine self-administration in the rat Psychopharmacol 198 2008 351 362
27. P. Rada, K. Jensen, and B.G. Hoebel Effects of nicotine and mecamylamine-induced withdrawal on extracellular dopamine and acetylcholine in the rat nucleus accumbens Psychopharmacology 157 2001 105 110 (Pubitemid 32758966)
28. S. Rahman, J. Zhang, E.A. Engleman, and W.A. Corrigall Neuroadaptive changes in the mesoaccumbens dopamine system after chronic nicotine self-administration: a microdialysis study Neurosci 129 2004 415 424 (Pubitemid 39388860)
29. C. Reavill, B. Bond, P. Overend, and A.J. Hunter Pharmacological characterization of the discriminative stimulus properties of the dopamine D1 agonist, SKF 81297 Behav Pharmacol 4 1993 135 146 (Pubitemid 23105380)
30. S. Rosenzweig-Lipson, and J. Bergman Dopamine D1 receptor involvement in the discriminative-stimulus effects of SKF 81297 in squirrel monkeys J Pharmacol Exp Ther 267 1993 765 775
31. 26]-NPY on the deficit in brain reward function and somatic signs associated with nicotine withdrawal in rats Neuropeptides 42 2008 215 227
32. J.A. Siuciak, and R.A. Fujiwara The activity of pramipexole in the mouse forced swim test is mediated by D2 rather than D3 receptors Psychopharmacol 175 2004 163 169 (Pubitemid 39222346)
33. H. Takahashi, Y. Takada, N. Nagai, T. Urano, and A. Takada Effects of nicotine and footshock stress on dopamine release in the striatum and nucleus accumbens Brain Res Bull 45 1998 157 162 (Pubitemid 28027797)